Collaborative Drug Discovery (CDD)

How can biotech companies optimize data access while going virtual?

This article is brought to you by: 

There is mounting pressure for companies to ensure that non-essential personnel work from home. The challenge, of course, is to operate in a virtual capacity without sacrificing productivity – in particular for biotech companies engaging in drug discovery where timely access to data can make or break an organization.

Synergy between man and machine

The failure of a candidate drug can cost millions – so many chemists are turning to software that provides modelling capabilities and multi-parameter optimisation

Subscribe to RSS - Collaborative Drug Discovery (CDD)